UPDATE : Wednesday, August 21, 2019
상단여백
기사 (전체 1,559건)
기사보기
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
GC’s Chinese partner applies for Hunter syndrome drug’s sales approvalGC said that CANBridge P...
Lee Han-soo  |  2019-07-30 10:49
기사보기
‘FDA likely to OK 11 blockbuster candidates in August’
‘FDA likely to OK 11 blockbuster candidates in August’The U.S. Food and Drug A...
Kim Yun-mi  |  2019-07-29 16:55
기사보기
Top-30 makers produce more than half of drugs
Top-30 makers produce more than half of drugsDrug output by 30 larges...
Lee Hye-seon  |  2019-07-29 16:38
기사보기
Takeda’s Zejula poised to change local ovarian cancer treatment market
Takeda’s Zejula poised to change local ovarian cancer treatment marketTakeda’s Zejula (ingredi...
Kim Yun-mi  |  2019-07-29 12:04
기사보기
Court extends ‘temporary suspension’ of order to cancel Invossa trials
Court extends ‘temporary suspension’ of order to cancel Invossa trialsA local court has decide...
Jeong Sae-im  |  2019-07-26 17:50
기사보기
SNUBH professor is 1st Asian keynoter at international Alzheimer meet
SNUBH professor is 1st Asian keynoter at international Alzheimer meetProfessor Kim Sang-yun o...
Lee Han-soo  |  2019-07-26 16:08
기사보기
‘Kolon Life Science to start following up on Invossa-treated patients’
‘Kolon Life Science to start following up on Invossa-treated patients’Kolon Life Science will ...
Lee Han-soo  |  2019-07-26 12:21
기사보기
JW Creagene wins US patent for making dendritic cell treatment
JW Creagene wins US patent for making dendritic cell treatmentJW Creagene said Thursda...
Lee Han-soo  |  2019-07-25 16:39
기사보기
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in Korea
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in KoreaMerck and Pfizer will ad...
Lee Han-soo  |  2019-07-25 15:18
기사보기
[Focus] Korean biopharmas eye US Humira market
[Focus] Korean biopharmas eye US Humira marketSamsung Bioepis’s Humira...
Jeong Sae-im  |  2019-07-25 15:02
기사보기
Kolon Life Science ends Invossa deal with Hong Kong partner
Kolon Life Science ends Invossa deal with Hong Kong partnerKolon Life Science said ...
Lee Han-soo  |  2019-07-25 11:17
기사보기
Tecentriq 1st immunotherapy to get coverage regardless of PD-L1 expression
Tecentriq 1st immunotherapy to get coverage regardless of PD-L1 expressionRoche said Tecentriq, it...
Lee Han-soo  |  2019-07-24 11:59
-12345678910-

Back to Top